151 related articles for article (PubMed ID: 3657712)
21. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of neuroblastoma using metaiodobenzylguanidine.
Edeling CJ; Frederiksen PB; Kamper J; Jeppesen P
Clin Nucl Med; 1987 Aug; 12(8):632-7. PubMed ID: 3665302
[TBL] [Abstract][Full Text] [Related]
23. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after.
Hör G; Maul FD; Kornhuber B; Schwabe D; Hesse J; Manegold KH; Baüm RP; Gerein V
J Nucl Biol Med (1991); 1991; 35(4):207-15. PubMed ID: 1823820
[TBL] [Abstract][Full Text] [Related]
24. Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives.
Beierwaltes WH
Med Pediatr Oncol; 1987; 15(4):188-91. PubMed ID: 3657705
[TBL] [Abstract][Full Text] [Related]
25. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
26. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
27. [131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma].
Berthold F; Feine U; Fischer M; Gerein V; Klingebiel T; Maul FD; Waters W; Wehinger H; Treuner J
Klin Padiatr; 1988; 200(3):226-9. PubMed ID: 3062260
[TBL] [Abstract][Full Text] [Related]
28. Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
Parisi MT; Matthay KK; Huberty JP; Hattner RS
Radiology; 1992 Aug; 184(2):463-7. PubMed ID: 1620849
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
[TBL] [Abstract][Full Text] [Related]
30. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
31. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
[TBL] [Abstract][Full Text] [Related]
33. 131I-MIBG therapy of neural crest tumours (review).
Troncone L; Rufini V
Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
[TBL] [Abstract][Full Text] [Related]
34. [Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
Murashima S; Takeda K; Okuda Y; Nakagawa T; Sakurai M
Kaku Igaku; 1990 Dec; 27(12):1393-400. PubMed ID: 2290210
[TBL] [Abstract][Full Text] [Related]
35. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
Klingebiel T; Reuland P; Feine U; Niethammer D
Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
[TBL] [Abstract][Full Text] [Related]
37. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
Mastrangelo R; Tornesello A; Riccardi R; Lasorella A; Mastrangelo S; Mancini A; Rufini V; Troncone L
Eur J Cancer; 1995; 31A(4):606-11. PubMed ID: 7576979
[TBL] [Abstract][Full Text] [Related]
38. MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group.
Treuner J; Gerein V; Klingebiel T; Schwabe D; Feine U; Happ J; Niethammer D; Maul F; Dopfer R; Kornhuber B
Prog Clin Biol Res; 1988; 271():669-78. PubMed ID: 3406023
[TBL] [Abstract][Full Text] [Related]
39. 131-Metaiodobenzylguanedine therapy of neuroblastoma in childhood. One year of therapeutic experience.
Schwabe D; Sahm S; Gerein V; Happ J; Kropp-von Rabenau H; Maul F; Baum RP; Manegold K; Nitz C; Hör G
Eur J Pediatr; 1987 May; 146(3):246-50. PubMed ID: 3595643
[TBL] [Abstract][Full Text] [Related]
40. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study.
Fielding SL; Flower MA; Ackery D; Kemshead JT; Lashford LS; Lewis I
Eur J Nucl Med; 1991; 18(5):308-16. PubMed ID: 1936038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]